Arrow-right Camera

The Spokesman-Review Newspaper The Spokesman-Review

Thursday, September 19, 2019  Spokane, Washington  Est. May 19, 1883
Cloudy 50° Cloudy
News >  Spokane

New Melanoma Vaccine Could Be Offered In Canada By March

By From Staff And Wire Reports

Ribi ImmunoChem could have its new melanoma vaccine on Canadian markets by March, an official for the Hamilton pharmaceutical company said.

Melacine, the company’s submission for a melanoma vaccine, has cleared a 45-day preliminary review by the Canadian Health Protection Branch, said Vern Child, Ribi’s vice president for finance. That cleared the way for a six-month “fast track” review of the drug.

“They have six months to do the detailed review,” Child said “So it could be approved as early as March 1998 and available for sale not far after that.”

Subscribe to the Morning Review newsletter

Get the day’s top headlines delivered to your inbox every morning by subscribing to our newsletter.

You have been successfully subscribed!
There was a problem subscribing you to the newsletter. Double check your email and try again, or email webteam@spokesman.com